|
Volumn 27, Issue 3, 2004, Pages 234-236
|
Neurooncology - Present and future
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTITHROMBIN;
BOSWELLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
DEXAMETHASONE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
ERLOTINIB;
IMATINIB;
PROTEIN INHIBITOR;
STEROID;
UNCLASSIFIED DRUG;
BRAIN CANCER;
BRAIN EDEMA;
BRAIN METASTASIS;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER THERAPY;
COMPUTER ASSISTED TOMOGRAPHY;
DENDRITIC CELL;
DRUG MEGADOSE;
EDITORIAL;
EPENDYMOMA;
GLIOBLASTOMA;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
METABOLISM;
NEUROIMAGING;
NEUROLOGIC DISEASE;
NEUROPATHOLOGY;
NEUROSURGERY;
OLIGODENDROGLIOMA;
PALLIATIVE THERAPY;
PARANEOPLASTIC SYNDROME;
PATHOPHYSIOLOGY;
PATIENT CARE;
VACCINATION;
BRAIN TUMOR;
METASTASIS;
METHODOLOGY;
ONCOLOGY;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
HUMANS;
MEDICAL ONCOLOGY;
NEUROSURGICAL PROCEDURES;
PATIENT CARE MANAGEMENT;
|
EID: 3943102801
PISSN: 0378584X
EISSN: None
Source Type: Journal
DOI: 10.1159/000077972 Document Type: Editorial |
Times cited : (2)
|
References (5)
|